The type classification of the Children’s Health Supplement market distinguishes six product families: vitamins, minerals, herbal extracts, probiotics, omega‑3 fatty acids, and multivitamin blends. Vitamin products, such as A, B‑complex, and D, are the foundational layer, supporting a wide array of physiological processes and contributing to roughly one‑third of segment revenue when aggregated with mineral supplements. Minerals—including calcium, iron, and zinc—are often bundled with vitamins but are also sold as stand‑alone chelates, together adding another 20 % to market value. Herbal extracts, exemplified by echinacea and ginseng, occupy a niche 10 % share, reflecting cautious adoption due to regulatory scrutiny. Probiotic formulations, targeting gut microbiota balance, represent 12 % of sales and are expanding rapidly as clinical data accumulate. Omega‑3 fatty acid products, principally DHA/EPA, hold 15 % of the market, driven by neurodevelopment research. Multivitamin blends, integrating multiple nutrients into a single dosage form, account for the remaining 13 %. This type‑based market taxonomy enables analysts to assess product‑level dynamics within the broader Children’s Health Supplement segmentation.